Correlation Between Amgen and HCW Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amgen and HCW Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amgen and HCW Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amgen Inc and HCW Biologics, you can compare the effects of market volatilities on Amgen and HCW Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amgen with a short position of HCW Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amgen and HCW Biologics.

Diversification Opportunities for Amgen and HCW Biologics

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Amgen and HCW is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Amgen Inc and HCW Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HCW Biologics and Amgen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amgen Inc are associated (or correlated) with HCW Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HCW Biologics has no effect on the direction of Amgen i.e., Amgen and HCW Biologics go up and down completely randomly.

Pair Corralation between Amgen and HCW Biologics

Given the investment horizon of 90 days Amgen Inc is expected to under-perform the HCW Biologics. But the stock apears to be less risky and, when comparing its historical volatility, Amgen Inc is 34.65 times less risky than HCW Biologics. The stock trades about -0.14 of its potential returns per unit of risk. The HCW Biologics is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  45.00  in HCW Biologics on August 27, 2024 and sell it today you would earn a total of  16.00  from holding HCW Biologics or generate 35.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Amgen Inc  vs.  HCW Biologics

 Performance 
       Timeline  
Amgen Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amgen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
HCW Biologics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in HCW Biologics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, HCW Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.

Amgen and HCW Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amgen and HCW Biologics

The main advantage of trading using opposite Amgen and HCW Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amgen position performs unexpectedly, HCW Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HCW Biologics will offset losses from the drop in HCW Biologics' long position.
The idea behind Amgen Inc and HCW Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments